Property	Value
Status
Version
Ad File
Disable Ads Flag
Environment
Moat Init
Moat Ready
Contextual Ready
Contextual URL
Contextual Initial Segments
Contextual Used Segments
AdUnit
SubAdUnit
Custom Targeting
Ad Events
Invalid Ad Sizes

Deepak L. Bhatt MD, MPH, FACC, FAHA, FESC, MSCAI Advisory Board

Peter Libby MD Advisory Board

See All Experts

featured

Published in Cardiology

Journal Scan / Research · February 06, 2014

Novel Genetic Markers Associated With Atrial Fibrillation Risk

Journal of the American College of Cardiology

Save Recommend

Sign in to PracticeUpdate

Only registered members have full access to PracticeUpdate content.

Not a member?

Join for free

Disclosure statements are available on the authors' profiles:

Patrick Ellinor MD, PhD

Steven Lubitz MD, MPH

Journal of the American College of Cardiology

Novel Genetic Markers Associate With Atrial Fibrillation Risk in Europeans and Japanese

J Am Coll Cardiol 2014 Jan 29;[EPub Ahead of Print], SA Lubitz, KL Lunetta, H Lin, DE Arking, S Trompet, G Li, BP Krijthe, DI Chasman, J Barnard, ME Kleber, M Dörr, K Ozaki, AV Smith, M Müller-Nurasyid, S Walter, SK Agarwal, JC Bis, JA Brody, LY Chen, BM Everett, I Ford, OH Franco, TB Harris, A Hofman, S Kääb, S Mahida, S Kathiresan, M Kubo, LJ Launer, PW MacFarlane, JW Magnani, B McKnight, DD McManus, A Peters, BM Psaty, LM Rose, JI Rotter, G Silbernagel, JD Smith, N Sotoodehnia, DJ Stott, KD Taylor, A Tomaschitz, T Tsunoda, AG Uitterlinden, DR van Wagoner, U Völker, H Völzke, JM Murabito, MF Sinner, V Gudnason, SB Felix, W März, M Chung, CM Albert, BH Stricker, T Tanaka, SR Heckbert, JW Jukema, A Alonso, EJ Benjamin, PT Ellinor

Novel Genetic Markers Associated With Atrial Fibrillation Risk

Additional Info

Novel Genetic Markers Associate With Atrial Fibrillation Risk in Europeans and Japanese

Further Reading

Prognostic Implications of Clinical and Imaging Diagnostic Criteria for Myocarditis

Association Between Delay to First Shock and Successful First-Shock Ventricular Fibrillation Termination in Patients With Witnessed Out-of-Hospital Cardiac Arrest

Comparison of Drug Routes in Out-of-Hospital Cardiac Arrest

Transcatheter Valve Replacement in Severe Tricuspid Regurgitation

Unidirectional Association of Clonal Hematopoiesis With Atherosclerosis Development

TAVR in Patients With Asymptomatic Severe Aortic Stenosis

Prehospital Pulse-Dose Glucocorticoid in Patients With ST-Segment Elevation Myocardial Infarction

The Burden of Diabetes-Associated Multiple Long-Term Conditions on Years of Life Spent and Lost

TAVR in Younger Patients With Severe Aortic Stenosis at Low Surgical Risk: 3-Year Outcomes

Cardiovascular Events Following COVID-19 Vaccination in Adults

Conduction Disturbances and Outcomes After Surgical Aortic Valve Replacement in Patients With Bicuspid and Tricuspid Aortic Stenosis

Recently Updated